Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer.
Ghochikyan A, Pichugin A, Bagaev A, Davtyan A, Hovakimyan A, Tukhvatulin A, Davtyan H, Shcheblyakov D, Logunov D, Chulkina M, Savilova A, Trofimov D, Nelson EL, Agadjanyan MG, Ataullakhanov RI.
Ghochikyan A, et al. Among authors: pichugin a.
J Transl Med. 2014 Nov 29;12:322. doi: 10.1186/s12967-014-0322-y.
J Transl Med. 2014.
PMID: 25432242
Free PMC article.